GROUP-BASED TRAJECTORY MODELING TO IDENTIFY RESPONSE PATTERNS TO OZANIMOD TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS

Stefan Schreiber  ¹     Brian G. Feagan  ²     Bruce E. Sands  ³     Florian Rieder  ⁴     Zhaohui Liu  ⁵     Anjali Jain  ⁵     Hsiuanlin Wu  ⁵     Mark Osterman  ⁵     Maria T. Abreu  ⁶     Parambir S. Dulai  ^7    
1 Department of Internal Medicine I, University Hospital Schleswig-Holstein, Kiel University, Kiel, Germany
² Robarts Research Institute, Western University, London, Ontario, Canada
³ Icahn School of Medicine at Mount Sinai, New York, United States
⁴ Department of Gastroenterology, Hepatology and Nutrition, Digestive Diseases and Surgery Institute, Cleveland Clinic, Cleveland, United States
⁵ Bristol Myers Squibb, Princeton, United States
⁶ University of Miami, Miller School of Medicine, Miami, United States
⁷ Feinberg School of Medicine, Northwestern University, Chicago, United States

Topic
IBD

Session
Targeting immune cell trafficking in IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)